Cough Into A Smartphone: How An AIIMS-Validated AI Software Is Screening For COPD In Under 10 Minutes

Cough sounds carry disease-specific acoustic signatures. By analysing these signatures using an AI-based algorithm, the ...
Medscape

Could Singing Aid in Pulmonary Rehab?

As more research finds evidence of QOL benefits, pulmonologists ponder bringing new singing programs to their patients.
Scientific Research Publishing

A Conceptual Paper Applying the Precede-Proceed Model to Person-Centred COPD Care: A Timely Resource for Patients, Clinicians, Health Organisations and Healthcare Policymakers ()

1 School of Nursing, Midwifery and Health Systems, University College Dublin, Dublin, Ireland. 2 Department of Nursing, Midland Regional Hospital, Portlaoise, Ireland. 3 Department of Public Health, ...
Morningstar

AirNexis Therapeutics Launches with $200M Series A to Advance Phase 2 Dual PDE3/4 Inhibitor AN01 for Chronic Obstructive Pulmonary Disease (COPD)

Company founded by Frazier Life Sciences, which led the Series A financing with participation from OrbiMed, Life Sciences at Goldman Sachs Alternatives, SR One, Longitude Capital and Enavate Sciences ...
openaccessgovernment

Only 1 in 10 gets the right care for COPD

A shock survey by charity Asthma + Lung UK reveals that more than 90% of people with COPD are receiving inadequate care, with those living in more deprived communities five times more likely to die ...
Frontiers

Exercise-responsive circTSN as a potential systemic biomarker during COPD rehabilitation

Chronic Obstructive Pulmonary Disease (COPD) features both pulmonary and systemic manifestations. While exercise is a proven therapeutic strategy, the specific non-coding RNAs mediating the systemic ...
The Gazette

Living with COPD

This simple diagram shows a healthy lung (left) and one with chronic obstructive pulmonary disease, or COPD. (AdobeStock) Buy Photo The Gazette offers audio versions of articles using Instaread. Some ...
Tribune Chronicle

Variety of treatments available for COPD

DEAR DR. ROACH: After over 50 years of smoking, my wife has chronic obstructive pulmonary disease and bad scarring of her lungs, but fortunately she doesn’t have cancer. She had respiratory syncytial ...
FierceBiotech

Expedition resupplies for phase 2 COPD voyage with $165M series A

Expedition Therapeutics is gearing up for a phase 2 trek with a $165 million series A that closed Oct. 9. The new funding will fuel the Bay Area biotech’s DPP1 inhibitor EXPD-101 as it ventures into a ...
MedPage Today

First-Ever Biologic Approved for COPD

The FDA approved dupilumab (Dupixent) as the first biologic treatment for adults with chronic obstructive pulmonary disease (COPD), Sanofi and Regeneron announced on Friday. An injectable interleukin ...
MedPage Today

Pulmonary Rehabilitation for COPD Pushes Forward

Home-based pulmonary rehabilitation has been slowly gaining momentum for chronic obstructive pulmonary disease (COPD), but access is still a challenge. "The science shows that there is greater benefit ...